Your browser doesn't support javascript.
loading
Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting.
Meecham, Amelia; Miranda, Elena; Morris, Hayley T; Hair, Jane; Oien, Karin A; Gerrard, Gareth; Guppy, Naomi; Mooney, David; Shaw, Emily C; Ashton-Key, Margaret; Lees, Robert; Flanagan, Adrienne; Rodriguez-Justo, Manuel.
Afiliação
  • Meecham A; Research Department of Pathology, UCL Cancer Institute, London, UK.
  • Miranda E; Research Department of Pathology, UCL Cancer Institute, London, UK.
  • Morris HT; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Hair J; NHS Research Scotland Greater Glasgow and Clyde Biorepository, Glasgow, UK.
  • Oien KA; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Gerrard G; Research Department of Pathology, UCL Cancer Institute, London, UK.
  • Guppy N; Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London, UK.
  • Mooney D; Research Department of Pathology, UCL Cancer Institute, London, UK.
  • Shaw EC; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Ashton-Key M; Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Lees R; Cancer Sciences Unit, University of Southampton, Southampton, UK.
  • Flanagan A; Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Rodriguez-Justo M; Cancer Sciences Unit, University of Southampton, Southampton, UK.
Histochem Cell Biol ; 156(6): 595-607, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34905068
Formalin is the principal tissue fixative used worldwide for clinical and research purposes. Despite optimal preservation of morphology, its preservation of DNA and RNA is poor. As clinical diagnostics increasingly incorporates molecular-based analysis, the requirement for maintaining nucleic acid quality is of increasing importance. Here we assess an alternative non-formalin-based tissue fixation method, PAXgene Tissue system, with the aim of better preserving nucleic acids, while maintaining the quality of the tissue to be used for vital existing diagnostic techniques. In this study, these criteria are assessed in a clinically representative setting. In total, 203 paired PAXgene Tissue and formalin-fixed samples were obtained. Blind-scored haematoxylin and eosin (H&E) sections showed comparable and acceptable staining. Immunohistochemistry (IHC) staining was suboptimal using existing protocols but improved with minor method adjustment and optimisation. Quality of DNA and RNA was significantly improved by PAXgene tissue fixation [RIN 2.8 versus 3.8 (p < 0.01), DIN 5.68 versus 6.77 (p < 0.001)], which translated into improved performance on qPCR assay. These results demonstrate the potential of PAXgene Tissue to be used routinely in place of formalin, maintaining adequate histological staining and significantly improving the preservation of biological molecules in the genomic era.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article